日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Functional, Cohort-Level Assessment of CFTR Modulator Responses Using Biobanked Nasal Epithelial Cells from Individuals with Cystic Fibrosis

利用囊性纤维化患者生物样本库中的鼻上皮细胞,对 CFTR 调节剂反应进行功能性、队列水平评估

Aalbers, Bente L; Amatngalim, Gimano D; Aarts, Ellen M; Rodenburg, Lisa W; den Hertog-Oosterhoff, Loes A; Heijerman, Harry G M; Beekman, Jeffrey M

Scedosporium infection as a late complication after start of elexacaftor/tezacaftor/ivacaftor: two case reports

依来卡夫托/替扎卡夫托/伊伐卡夫托治疗后晚期并发症:镰孢菌感染:两例病例报告

van Mourik, P; van der Hout, E C; Luijk, H D; Hofland, R W; Bruns, A H W; Heijerman, H G M; Bronsveld, I

Evaluation of Elexacafor/Tezacaftor/Ivacaftor therapy after lung transplantation in Cystic Fibrosis: The Dutch National KOALA study

囊性纤维化肺移植术后Elexacafor/Tezacaftor/Ivacaftor疗法的评估:荷兰国家KOALA研究

van Gemert, Johanna P; Luijk, Bart; Hellemons, Merel E; Visser, Klara A; Hansen, Carina M E; van der Meer, Renske; Gan, C Tji; van der Vaart, Hester; Akkerman, Onno W; Steenhuis, Willie N; Verkleij, Marieke; Heijerman, Harry G M; Verschuuren, Erik A M

Tackle your Tics, a brief intensive group-based exposure treatment for young people with tics: results of a randomised controlled trial

应对抽动症:一项针对青少年抽动症患者的短期强化小组暴露疗法:一项随机对照试验的结果

Heijerman-Holtgrefe, A P; Huyser, C; Bus, M; Beljaars, L P L; van de Griendt, J M T M; Verdellen, C W J; Kan, K J; Zijlstra, B J H; Lindauer, R J L; Cath, D C; Hoekstra, P J; Utens, E M W J

Considerations for the use of inhaled antibiotics for Pseudomonas aeruginosa in people with cystic fibrosis receiving CFTR modulator therapy

考虑在接受 CFTR 调节剂治疗的囊性纤维化患者中使用吸入性抗生素治疗铜绿假单胞菌感染

Burgel, Pierre-Régis; Ballmann, Manfred; Drevinek, Pavel; Heijerman, Harry; Jung, Andreas; Mainz, Jochen G; Peckham, Daniel; Plant, Barry J; Schwarz, Carsten; Taccetti, Giovanni; Smyth, Alan

Development and validation of a novel personalized electronic patient-reported outcome measure to assess quality of life (Q-LIFE): a prospective observational study in people with Cystic Fibrosis

开发和验证一种新型的个性化电子患者报告结局测量工具(Q-LIFE)以评估生活质量:一项针对囊性纤维化患者的前瞻性观察研究

Muilwijk, Danya; van Paridon, Tessa J; van der Heijden, Doris C; Faber-Bisschop, Brenda M; Zomer-van Ommen, Domenique D; Heijerman, Harry G M; van der Ent, Cornelis K

Validation of the CaReQoL asthma: a patient reported outcome measure for monitoring the perceived effects of pulmonary rehabilitation in adult patients with severe refractory asthma

CaReQoL哮喘量表的验证:一种用于监测重度难治性哮喘成人患者肺康复治疗效果的患者报告结局指标

Springvloet, Linda; Triemstra, Mattanja; Knottnerus, Bart; Rolink, Marlon; Heijerman, Harry; de Boer, Dolf

The effect of azithromycin on sputum inflammatory markers in bronchiectasis

阿奇霉素对支气管扩张患者痰液炎症标志物的影响

Terpstra, L C; Altenburg, J; Doodeman, H J; Piñeros, Y S Sabogal; Lutter, R; Heijerman, H G M; Boersma, W G

Treatment with inhaled antibiotics in bronchiectasis, side effects, and evaluation of the tolerance test; analysis from the BATTLE randomized controlled trial

吸入抗生素治疗支气管扩张症、副作用及耐受性试验评估;来自 BATTLE 随机对照试验的分析

Terpstra, Lotte C; van der Geest, Daphne; Bronsveld, Inez; Heijerman, Harry; Boersma, Wim G

Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis

长期每日一次吸入妥布霉素溶液(TIS)对非囊性纤维化支气管扩张患者病情加重率的影响

Terpstra, Lotte C; Altenburg, Josje; Bronsveld, Inez; de Kruif, Martijn D; Berk, Yvonne; Snijders, Dominic; Rozemeijer, Wouter; Heijerman, Harry G M; Boersma, Wim G